Comerica Bank
CGON icon

Comerica Bank’s CG Oncology CGON Stock Holding History

Comerica Bank’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$42.7K Buy
1,028
+515
+100% +$21.3K ﹤0.01% 2909
2025
Q3 		$20.7K Buy
513
+110
+27% +$3.2K ﹤0.01% 3082
2025
Q2 		$10.5K Buy
403
+348
+633% +$8.39K ﹤0.01% 3197
2025
Q1 		$1.35K Hold
55
– – ﹤0.01% 3532
2024
Q4 		$1.58K Hold
55
– – ﹤0.01% 3518
2024
Q3 		$2.08K Hold
55
– – ﹤0.01% 3491
2024
Q2 		$1.74K Hold
55
– – ﹤0.01% 3520
2024
Q1 		$2.41K Buy
+55
New +$2.25K ﹤0.01% 3496

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Comerica Bank's CGON Position: Q4 2025 in Review

Comerica Bank increased its CG Oncology (CGON) stake by 100% in Q4 2025, buying an estimated $21.3K and bringing the position to 1,028 shares worth $42.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2909.

Comerica Bank first reported a position in CGON in Q1 2024 and has held it in 8 quarters since. 195 funds tracked by Wall St. Rank hold CGON as of Q4 2025.

  • Comerica Bank held 1,028 shares of CG Oncology worth $42.7K as of Q4 2025.
  • Comerica Bank bought 515 CG Oncology shares in Q4 2025, an estimated $21.3K.
  • CG Oncology made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2909 holding.
  • Comerica Bank first reported a position in CG Oncology in Q1 2024 and has held it in 8 quarters since.
  • 195 funds tracked by Wall St. Rank held CG Oncology as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.